AXQ Capital’s Oric Pharmaceuticals ORIC Stock Holding History

AXQ Capital’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,366	Closed	-$84.8K	–	1195
2025 Q4	$84.8K	Buy	+10,366	New	+$119K	0.02%	671
2025 Q3	–	Sell	-12,950	Closed	-$131K	–	760
2025 Q2	$131K	Buy	12,950 +2,889	+29%	+$19.4K	0.04%	498
2025 Q1	$56.1K	Buy	+10,061	New	+$88K	0.02%	466

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

AXQ Capital's ORIC Position: Q1 2026 in Review

AXQ Capital sold out of Oric Pharmaceuticals (ORIC) in Q1 2026, closing a stake of 10,366 shares — an estimated $84.8K sold.

AXQ Capital first reported a position in ORIC in Q1 2025 and held it in 3 quarters. The position peaked at $131K in Q2 2025. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

AXQ Capital reported no remaining Oric Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
AXQ Capital sold 10,366 Oric Pharmaceuticals shares in Q1 2026, an estimated $84.8K.
AXQ Capital first reported a position in Oric Pharmaceuticals in Q1 2025 and held it in 3 quarters.
AXQ Capital's Oric Pharmaceuticals position peaked at $131K in Q2 2025.
182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.